CEA doubling time in relapsed cases of lung cancer.
نویسندگان
چکیده
منابع مشابه
Avoiding overdiagnosis in lung cancer screening: the volume doubling time strategy.
It has been 2 years since the breakthrough publication of the National Lung Cancer Screening Trial (NLST) results, yet there are still unresolved questions about cancer screening. Despite the possibility of reducing lung cancer-related mortality, the risk of detecting indolent lesions that are not life threatening, especially in advanced-age patients, still exists. Another problem is the number...
متن کاملTopotecan in the treatment of relapsed small cell lung cancer
Small cell lung cancer (SCLC) represents about 15% to 20% of all lung cancers. Chemotherapy is the cornerstone of the treatment, cisplatin-etoposide combination being the most used combination as first-line therapy. Despite high initial chemosensitivity, most SCLC patients will experience relapse sooner or later. Unfortunately, second-line chemotherapy does not result in a high response rate li...
متن کاملRole of Adenosine receptor in lung cancer
Summary: Adenosine through adenosine receptor have a crucial role in biology of lung cancer. Recent study indicated adenosine receptors have a crucial role in various aspect of lung cancer from cell growth and metastasis to modulation of apoptosis and it could be considered as a potential candidate for treatment of the lung cancer.
متن کاملTumor doubling time and prognostic assessment of patients with primary lung cancer.
BACKGROUND Relationships between tumor doubling time (DT) and other prognostic factors and the risk of death related to these factors are not yet fully understood. METHODS Tumor doubling time of primary lung carcinomas of 174 patients, detected in a limited number of local municipalities during a limited period, was calculated using the Schwartz formula. Survival rate of the 174 patients was ...
متن کاملSmall Cell Lung Cancer Doubling Time and its Effect on Clinical Presentation: A Concise Review
Small cell lung cancer (SCLC) is one of many types rapidly growing malignant diseases, such as Burkitt's lymphoma and testicular germ cell cancers. At present, there is no reliable way to screen for SCLC, and imaging modalities tend to be delayed in detecting this type of cancer. The clinical presentation of acutely and rapidly growing SCLC can mimic those of pulmonary inflammatory or infectiou...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Haigan
سال: 1990
ISSN: 1348-9992,0386-9628
DOI: 10.2482/haigan.30.167